Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Substance Use Disorders Affecting Sleep

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...

Stress and Mental Health

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Flavour and brand of nicotine pouches used most often among US adolescents, 2025.

Tobacco control·2026

Same author

Marijuana and Delta-8-THC Use Among U.S. Adolescents Between 2023 and 2024.

American journal of preventive medicine·2026

Same author

E-Cigarette, Nicotine Pouch, and Other Oral Nicotine Product Concept Flavor Use Descriptives and Associations with Demographics and Product Use Characteristics.

Substance use & misuse·2026

Same author

Effects of nicotine concentration and pH on nicotine pouch appeal and sensory experience: A randomized experimental study.

Addiction (Abingdon, England)·2026

Same author

Social Media Discussions of Emerging Nicotine Analogue Products: A Content Analysis of Reddit and X.

Substance use & misuse·2026

Same author

Factors Associated with Exposure to Nicotine Pouch Content on Social Media among U.S. Adolescents.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026

Search research articles

Related Experiment Video

Updated: Jul 1, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Associations between depression subtypes and substance use disorders.

Adam M Leventhal¹, Caren Francione Witt, Mark Zimmerman

¹Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02912, United States. adam_leventhal@brown.edu

Psychiatry Research

|September 16, 2008

Summary

Melancholic depression subtypes show higher rates of nicotine dependence and drug use disorders compared to undifferentiated depression. Specific melancholic features explain these associations, suggesting differential links between Major Depressive Disorder subtypes and substance use disorders.

More Related Videos

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Related Experiment Videos

Last Updated: Jul 1, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

A New Method for Inducing a Depression-Like Behavior in Rats

A New Method for Inducing a Depression-Like Behavior in Rats

Published on: February 22, 2018

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Area of Science:

Psychiatry
Clinical Psychology
Neuroscience

Background:

Major Depressive Disorder (MDD) and Substance Use Disorders (SUDs) frequently co-occur.
Understanding the relationship between MDD subtypes and SUDs is crucial for targeted interventions.

Purpose of the Study:

To investigate the association between distinct DSM-IV defined subtypes of Major Depressive Disorder and the prevalence of current Substance Use Disorders.
To identify specific depressive symptoms that may mediate the relationship between MDD subtypes and SUDs.

Main Methods:

A comparative study of psychiatric outpatients diagnosed with unipolar MDD.
Assessment using the Structured Clinical Interview for DSM-IV and supplemental questions.
Analysis controlled for demographic and clinical variables.

Main Results:

Melancholic depression subtypes exhibited significantly higher rates of nicotine dependence and drug abuse/dependence compared to undifferentiated depression.
Specific melancholic features, including psychomotor agitation and significant weight loss or decreased appetite, were associated with increased nicotine and drug use disorders.
No significant associations were found between atypical depression, atypical-melancholic depression, or other MDD subtypes and SUDs.

Conclusions:

Different symptomatic presentations of Major Depressive Disorder are differentially associated with specific Substance Use Disorders.
The findings suggest that melancholic depression, particularly with specific associated features, warrants closer attention regarding co-occurring SUDs.